Acute upper gastrointestinal bleeding remains the most common medical emergency managed by gastroenterologists, with an incidence of 37-172 per 100,000 of the population per year. Despite advances in medical and endoscopic treatment, morality remains at between 3 and 14%, rising to 33% for patients developing secondary upper gastrointestinal bleeding following admission for other reasons [1, 2] . Gastroduodenal ulcer disease is the commonest cause of upper gastrointestinal bleeding, accounting for almost 50% of admission caused by acute upper gastrointestinal bleeding, with 15,000 annual hospital admissions in the United States and an estimated cost of $750 million [3, 4] .
Several factors including advanced age, severe comorbidity, coagulopathy, hemodynamic instability, hematemesis, or hematochezia are predictors of recurrent bleeding. In addition, the appearance of gastric or duodenal ulcer base (Table 1) is one of the most important factors, and is used to predict the risk of rebleeding, determine prognosis, and the need for therapy [5] [6] [7] . Active hemorrhage and non-bleeding visible vessels within an ulcer are associated with a high risk of rebleeding and necessitate endoscopic therapy [7] . Conversely, ulcers with a clean base or a flat spot rarely rebleed and can be managed medically, with early hospital discharge [8] .
Ulcers with adherent clots have an intermediate risk of recurrent bleeding depending on the appearance of the ulcer base. The question of whether this group of patients should have medical treatment or aggressive removal of the clot followed by endoscopic therapy if appropriate was analyzed in a meta-analysis. The meta-analysis identified six randomized trials that included 240 patients, who were randomized to endoscopic clot removal and treatment or medical management [9] . Rebleeding occurred in 8.2% in the endoscopic therapy group and 24.7% in the medical group. The endoscopic features of an ulcer are therefore key in assessing risk and guiding subsequent management in patients who present with an upper gastrointestinal ulcer bleeding.
Several approaches have been used to improve visibility during upper gastrointestinal bleeding. Gastric lavage can be performed prior to or during endoscopy using a large diameter nasogastric tube [10] . Prokinetic agents have been used to improve gastric emptying and thus improve visibility. The most commonly used is erythromycin, a motilin agonist, which promotes rapid gastric emptying after intravenous injection. Its role in improving visibility has been examined in two prospective randomized, controlled studies which demonstrated improved quality of endoscopic examination and resulted in a reduced need for second-look endoscopy in the patients randomized to receive erythromycin (3 mg/kg/IV 20-60 or 120 min before endoscopy) [11, 12] . Endoscopes with jumboinstrument channels, which allow the removal of blood and clot more efficiently, have also been used, however, these instruments have a larger diameter and generally have less retroflexion capability. Vigorous lavage with a water pump, or removing the clot with a cold snare, suction, biopsy forceps or use of a thermal probe have also been described [13] [14] [15] [16] . However, some of these modalities, such as cold snare clot removal, may precipitate bleeding. Three percent hydrogen peroxide (H 2 O 2 ) has been available for several years as a topical antiseptic and disinfectant for oral administration as an antiseptic agent in mouth rinses and as a tooth whitener. The role of H 2 O 2 in bleeding was first described in a canine model where it improved visualization in experimentally induced bleeding gastric ulcers [17] . A subsequent pilot study was performed in six patients with acute upper GI bleeding [18] . A blood clearance score (BCS; Table 2 ) was compared after flushing with water and then with 3% H 2 O 2 . The six patients had minimal or no clearance of blood after flushing with water, however, there was a significant improvement in the BCS after flushing with 3% H 2 O 2 (p = 0.03).
Three percent H 2 O 2 improves visualization in upper gastrointestinal bleeding by altering the characteristics of blood, rendering it translucent and easier to remove. The mechanism by which H 2 O 2 causes blood to become translucent is not known, but it is a powerful oxidizing agent and may damage the red cells, thereby causing hemolysis. Alternatively, catalase, which is present in all human red blood cells, causes degradation of H 2 O 2 , resulting in a rapid release of oxygen, which may increase mechanical trauma to red blood cells, promoting hemolysis. In addition, H 2 O 2 may also have a hemostatic effect.
The article by Sridhar et al. [19] in the November 2009 issue of Digestive Diseases and Sciences, examined the effect of 3% H 2 O 2 on ulcer visibility in patients with adherent clots in patients with acute non-variceal upper gastrointestinal bleeding. In this large, prospective, singlecenter study, all patients were administered intravenous proton pump inhibitor bolus followed by continuous infusion and underwent endoscopy within 6 h of admission. Prior to endoscopy, a gastric lavage was performed using 500 ml of water. Patients with a clot present at endoscopy were eligible for inclusion in the study. In this group of patients, the base of the ulcer was sprayed with 250 ml of water using a 5Fr spray tip catheter attached to a 30-ml syringe. Adherent clots, defined as those resistant to targeted water spray, were sprayed with up to 100 ml of 3% H 2 O 2 . The ulcer base was graded by the endoscopist using the BCS (Table 2 ) at the start of the procedure after the water lavage and following the application of H 2 O 2 . The change in the BCS after water and after H 2 O 2 was also graded by a blinded reviewer on images taken during the procedure.
Three hundred and twenty patients were screened, of whom 81 were eligible for inclusion in the study with adherent clots. The mean BCS visual score decreased from 0.06 before water application, to 0.78 after water application, and 2.83 after H 2 O 2 , with a significant improvement in the score (2.04; 95% CI 1.86-2.23) following application of H 2 O 2 . This was highly significant (p = 0.00), improving visibility in both gastric (n = 34) and duodenal ulcers (n = 47).
Lower volumes of H 2 O 2 were required (33 and 35 ml) for patients with duodenal or gastric ulcer on NSAIDS (n = 40), compared to those not taking NSAIDS (45 and 56 ml, respectively). The authors hypothesized that this may be because the clot is less stable due to platelet dysfunction. Importantly, no patient suffered any side-effects during a 1-month follow up.
There are some limitations of this study. It is a nonrandomized, non-placebo-controlled, single-center study. A potential confounding factor is the degree of vigor and method with which clots were irrigated, as gentle irrigation with a syringe may fail to expose the underlying stigmata. None of the patients in this study had clearance of the clot after water irrigation. This contrasts with a study by Laine et al. [13] who used a 3.2-mm bipolar probe to irrigate for up to 5 min, where only 57% of patients had clot remaining. Another study by Lin et al. [16] compared irrigation with a syringe with a water jet. Clots were removed using syringe irrigation in only 9% of 165 patients, whereas clots were removed in an additional 26% of patients with the water jet [16] .
The BCS score is subjective and the primary endoscopist was not blinded, which could be associated with observer bias. The authors examined the intra-observer and inter-observer agreement for the BCS score. The interobserver agreement on the BCS score between the endoscopist and the blinded observer was good with a kappa of 0.78 (95% CI 0.50-1.0; p = 0.001) before water, 0.80 Table 2 Blood clearance score (BCS) [18] Grade Description Helicobacter pylori infection was determined by the rapid urease test taken at the time of the upper endoscopy, which may have underestimated the number of patients infected. An important note in this study is that patients with clots larger than 2 cm were excluded from the study. The authors excluded this group as they had previously found H 2 O 2 was ineffective in this group.
Despite these limitations, this study clearly demonstrates the usefulness of H 2 O 2 in allowing visualization of the ulcer base in patients with adherent clot less than 2 cm. H 2 O 2 should be considered in all patients with non-visible ulcer base.
